Trexquant Investment LP Ptc Therapeutics, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 217,999 shares of PTCT stock, worth $9.24 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

217,999

Previous 298,422 26.95%

Holding current value

$9.24 Million

Previous $9.13 Million 11.38%

% of portfolio

0.11%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$30.39 - $37.66 $2.44 Million - $3.03 Million	-80,423 Reduced 26.95%	217,999 $8.09 Million
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $691,517 - $1.12 Million	28,008 Added 10.36%	298,422 $9.13 Million
Q1 2024 May 14, 2024	BUY	$24.15 - $31.95 $911,686 - $1.21 Million	37,751 Added 16.23%	270,414 $7.87 Million
Q4 2023 Feb 09, 2024	BUY	$18.07 - $29.37 $4.2 Million - $6.83 Million	232,663 New	232,663 $6.41 Million
Q4 2022 Feb 13, 2023	SELL	$33.53 - $54.79 $392,468 - $641,316	-11,705 Reduced 27.45%	30,933 $1.18 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $167,609 - $215,669	4,005 Added 10.37%	42,638 $2.14 Million
Q2 2022 Aug 11, 2022	BUY	$25.6 - $45.23 $321,868 - $568,676	12,573 Added 48.25%	38,633 $1.55 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $679,032 - $908,635	20,373 Added 358.24%	26,060 $972,000
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $51,660 - $61,157	-1,461 Reduced 20.44%	5,687 $227,000
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $3,849 - $4,652	-104 Reduced 1.43%	7,148 $266,000
Q2 2021 Aug 12, 2021	BUY	$37.95 - $49.37 $275,213 - $358,031	7,252 New	7,252 $307,000
Q4 2020 Feb 11, 2021	SELL	$47.96 - $67.64 $647,747 - $913,545	-13,506 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$45.41 - $57.07 $613,307 - $770,787	13,506 New	13,506 $631,000
Q2 2020 Aug 07, 2020	SELL	$42.56 - $54.98 $258,594 - $334,058	-6,076 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$32.37 - $59.36 $283,593 - $520,052	-8,761 Reduced 59.05%	6,076 $271,000
Q4 2019 Feb 12, 2020	BUY	$32.22 - $50.07 $478,048 - $742,888	14,837 New	14,837 $713,000
Q3 2019 Nov 08, 2019	SELL	$33.82 - $48.17 $442,196 - $629,822	-13,075 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$35.42 - $45.0 $182,979 - $232,470	5,166 Added 65.32%	13,075 $588,000
Q1 2019 May 13, 2019	BUY	$28.09 - $39.49 $222,163 - $312,326	7,909 New	7,909 $298,000
Q4 2018 Feb 13, 2019	SELL	$29.83 - $46.51 $728,120 - $1.14 Million	-24,409 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$33.9 - $47.77 $1.45 Million - $2.05 Million	-42,817 Reduced 63.69%	24,409 $1.15 Million
Q2 2018 Aug 07, 2018	BUY	$25.7 - $47.88 $1.73 Million - $3.22 Million	67,226 New	67,226 $2.27 Million

Others Institutions Holding PTCT

# of Institutions

219

Shares Held

78.2M

Call Options Held

111K

Put Options Held

30.6K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Ptc Therapeutics, Inc. Transaction History